Surveillance of Central Line–Associated Bloodstream Infections (CLABSI) in pediatric hematology-oncology patients


Intravenous literature: Gaur, A.H., Bundy, D.G., Gao, C., Werner, E.J., Billett, A.L., Hord, J.D., Siegel, J.D., Dickens, D., Winkle, C. and Miller, M.R. (2013) Surveillance of Hospital-Acquired Central Line–Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients: Lessons Learned, Challenges Ahead. Infection Control and Hospital Epidemiology. 34(3), p.316-320


Across 36 US pediatric oncology centers, 576 central line–associated bloodstream infections (CLABSIs) were reported over a 21-month period. Most infections occurred in those with leukemia and/or profound neutropenia. The contribution of viridans streptococci infections was striking. Study findings depict the contemporary epidemiology of CLABSIs in hospitalized pediatric cancer patients.

Main page


Comments are closed.